So far as our knowledge is concerned, no study has been evaluated in Indian lung cancer patients to evaluate the role of the MSH3 and MSH6 polymorphism towards lung cancer susceptibility and as a prognostic marker. The gene discussed is MSH3; the disease is lung carcinoma.